Impact of body mass index on the outcomes following transcatheter aortic valve implantation

Catheterization and Cardiovascular Interventions

Volumn 88, Issue 1, 2016, Pages 127-134

  Abramowitz, Yigal ^a   Chakravarty, Tarun ^a   Jilaihawi, Hasan ^a   Cox, Justin ^a   Sharma, Rahul P ^a   Mangat, Geeteshwar ^a   Nakamura, Mamoo ^a   Cheng, Wen ^a   Makkar, Raj R ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

aortic stenosis; obesity paradox; overweight; TAVI; transcatheter aortic valve replacement

Indexed keywords

AGED; AORTA STENOSIS; ARTICLE; BODY MASS; BODY WEIGHT; CHRONIC LUNG DISEASE; DIABETES MELLITUS; FEMALE; FRAIL ELDERLY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBESITY; PERCUTANEOUS AORTIC VALVE; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT OUTCOME; VERY ELDERLY;

EID: 84978792163     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.26394     Document Type: Article

References (29)

1. Anon. Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Arch Intern Med 1998; 158:1855–1867.
2. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, Eckel RH, American Heart Association, Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Obesity and cardiovascular disease: Pathophysiology, evaluation, and effect of weight loss: An update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006; 113:898–918.
3. Das SR, Alexander KP, Chen AY, Powell-Wiley TM, Diercks DB, Peterson ED, Roe MT, Lemos JAd. Impact of body weight and extreme obesity on the presentation, treatment, and in-hospital outcomes of 50,149 patients with ST-Segment elevation myocardial infarction results from the NCDR (National Cardiovascular Data Registry). J Am Coll Cardiol 2011; 58:2642–2650.
4. Gurm HS, Brennan DM, Booth J, Tcheng JE, Lincoff AM, Topol EJ. Impact of body mass index on outcome after percutaneous coronary intervention (the obesity paradox). Am J Cardiol 2002; 90:42–45.
5. Mehta L, Devlin W, McCullough PA, O'Neill WW, Skelding KA, Stone GW, Boura JA, Grines CL. Impact of body mass index on outcomes after percutaneous coronary intervention in patients with acute myocardial infarction. Am J Cardiol 2007; 99:906–910.
6. Hastie CE, Padmanabhan S, Slack R, Pell ACH, Oldroyd KG, Flapan AD, Jennings KP, Irving J, Eteiba H, Dominiczak AF, Pell JP. Obesity paradox in a cohort of 4880 consecutive patients undergoing percutaneous coronary intervention. Eur Heart J 2010; 31:222–226.
7. Gruberg L, Weissman NJ, Waksman R, Fuchs S, Deible R, Pinnow EE, Ahmed LM, Kent KM, Pichard AD, Suddath WO, Satler LF, Lindsay J. The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: The obesity paradox? J Am Coll Cardiol 2002; 39:578–584.
8. Roberts WC, Roberts CC, Vowels TJ, Ko JM, Filardo G, Hamman BL, Matter GJ, Henry AC, Hebeler RF. Effect of body mass index on survival in patients having aortic valve replacement for aortic stenosis with or without concomitant coronary artery bypass grafting. Am J Cardiol 2011; 108:1767–1771.
9. Smith RL, Herbert MA, Dewey TM, Brinkman WT, Prince SL, Ryan WH, Mack MJ. Does body mass index affect outcomes for aortic valve replacement surgery for aortic stenosis? Ann Thorac Surg 2012; 93:742–746. discussion 746–747.
10. Makkar RR, Fontana GP, Jilaihawi H, Kapadia S, Pichard AD, Douglas PS, Thourani VH, Babaliaros VC, Webb JG, Herrmann HC, Bavaria JE, Kodali S, Brown DL, Bowers B, Dewey TM, Svensson LG, Tuzcu M, Moses JW, Williams MR, Siegel RJ, Akin JJ, Anderson WN, Pocock S, Smith CR, Leon MB, PARTNER Trial Investigators. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med 2012; 366:1696–1704.
11. Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, Fontana GP, Dewey TM, Thourani VH, Pichard AD, Fischbein M, Szeto WY, Lim S, Greason KL, Teirstein PS, Malaisrie SC, Douglas PS, Hahn RT, Whisenant B, Zajarias A, Wang D, Akin JJ, Anderson WN, Leon MB, PARTNER Trial Investigators. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 2012; 366:168627.
12. Wenaweser P, Pilgrim T, Kadner A, Huber C, Stortecky S, Buellesfeld L, Khattab AA, Meuli F, Roth N, Eberle B, Erdös G, Brinks H, Kalesan B, Meier B, Jüni P, Carrel T, Windecker S. Clinical outcomes of patients with severe aortic stenosis at increased surgical risk according to treatment modality. J Am Coll Cardiol 2011; 58:2151–2162.
13. Boon RMAvd, Chieffo A, Dumonteil N, Tchetche D, Mieghem NMV, Buchanan GL, Vahdat O, Marcheix B, Serruys PW, Fajadet J, Colombo A, Carrié D, Domburg RTv, Jaegere PPTd, PRAGMATIC-plus Researchers. Effect of body mass index on short- and long-term outcomes after transcatheter aortic valve implantation. Am J Cardiol 2013; 111:231–236.
14. Konigstein M, Havakuk O, Arbel Y, Finkelstein A, Ben-Assa E, Leshem Rubinow E, Abramowitz Y, Keren G, Banai S. The obesity paradox in patients undergoing transcatheter aortic valve implantation. Clin Cardiol 2015; 38:76–81.
15. Yamamoto M, Mouillet G, Oguri A, Gilard M, Laskar M, Eltchaninoff H, Fajadet J, Iung B, Donzeau-Gouge P, Leprince P, Leuguerrier A, Prat A, Lievre M, Chevreul K, Dubois-Rande J-L, Teiger E, FRANCE 2 Registry Investigators. Effect of body mass index on 30- and 365-day complication and survival rates of transcatheter aortic valve implantation (from the FRench Aortic National CoreValve and Edwards 2 [FRANCE 2] registry). Am J Cardiol 2013; 112:1932–1937.
16. Kappetein AP, Head SJ, Généreux P, Piazza N, Mieghem NMv, Blackstone EH, Brott TG, Cohen DJ, Cutlip DE, Es G-Av, Hahn RT, Kirtane AJ, Krucoff MW, Kodali S, Mack MJ, Mehran R, Rodés-Cabau J, Vranckx P, Webb JG, Windecker S, Serruys PW, Leon MB. Updated standardized endpoint definitions for transcatheter aortic valve implantation: The Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol 2012; 60:1438–1454.
17. Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, Hollenbeck A, Leitzmann MF. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 2006; 355:763–778.
18. Niedziela J, Hudzik B, Niedziela N, Gąsior M, Gierlotka M, Wasilewski J, Myrda K, Lekston A, Poloński L, Rozentryt P. The obesity paradox in acute coronary syndrome: A meta-analysis. Eur J Epidemiol 2014; 29:801–812.
19. Carnethon MR, Rasmussen-Torvik LJ, Palaniappan L. The obesity paradox in diabetes. Curr Cardiol Rep 2014; 16:446
20. Dorner TE, Rieder A. Obesity paradox in elderly patients with cardiovascular diseases. Int J Cardiol 2012; 155:56–65.
21. Mohamed-Ali V, Goodrick S, Bulmer K, Holly JM, Yudkin JS, Coppack SW. Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. Am J Physiol 1999; 277:E971–975.
22. Rogge BP, Cramariuc D, Lønnebakken MT, Gohlke-Bärwolf C, Chambers JB, Boman K, Gerdts E. Effect of overweight and obesity on cardiovascular events in asymptomatic aortic stenosis: A SEAS substudy (Simvastatin Ezetimibe in Aortic Stenosis). J Am Coll Cardiol 2013; 62:1683–1690.
23. Rossi A, Gaibazzi N, Bellelli G, Nistri S, Cicoira M, Cioffi G, Faden G, Temporelli PL, Faggiano P. Obesity paradox in patients with aortic valve stenosis. Protective effect of body mass index independently of age, disease severity, treatment modality and non-cardiac comorbidities. Int J Cardiol 2014; 176:1441–1443.
24. Birkmeyer NJ, Charlesworth DC, Hernandez F, Leavitt BJ, Marrin CA, Morton JR, Olmstead EM, O'Connor GT. Obesity and risk of adverse outcomes associated with coronary artery bypass surgery. Northern New England Cardiovascular Disease Study Group. Circulation 1998; 97:1689–1694.
25. Vaduganathan M, Lee R, Beckham AJ, Andrei A-C, Lapin B, Stone NJ, McGee EC, Malaisrie SC, Kansal P, Silverberg RA, Lloyd-Jones DM, McCarthy PM. Relation of body mass index to late survival after valvular heart surgery. Am J Cardiol 2012; 110:1667–1678.
26. Sepehri A, Beggs T, Hassan A, Rigatto C, Shaw-Daigle C, Tangri N, Arora RC. The impact of frailty on outcomes after cardiac surgery: A systematic review. J Thorac Cardiovasc Surg 2014; 148:3110–3117.
27. Green P, Arnold SV, Cohen DJ, Kirtane AJ, Kodali SK, Brown DL, Rihal CS, Xu K, Lei Y, Hawkey MC, Kim RJ, Alu MC, Leon MB, Mack MJ. Relation of frailty to outcomes after transcatheter aortic valve replacement (from the PARTNER trial). Am J Cardiol 2015; 116:264–269.
28. Puls M, Sobisiak B, Bleckmann A, Jacobshagen C, Danner BC, Hünlich M, Beißbarth T, Schöndube F, Hasenfuß G, Seipelt R, Schillinger W. Impact of frailty on short- and long-term morbidity and mortality after transcatheter aortic valve implantation: Risk assessment by Katz Index of activities of daily living. EuroIntervention 2014; 10:609–619.
29. Banack HR, Kaufman JS. Does selection bias explain the obesity paradox among individuals with cardiovascular disease? Ann Epidemiol 2015; 25:342–349.